A new tyrosine kinase inhibitor - Imatinib

Min.Order / FOB Price:Get Latest Price

0 Metric Ton	Negotiable

0 Metric Ton

Negotiable

Min.Order :0 Metric Ton
Purity: 99%

Keywords

IMA-3 IMATINIB-D3 AKOS 91378

Quick Details

Appearance:
Application:It is used for the treatment of chronic myelocytic leukemia (CML) in various stages. It is also used to treat CD117 positive gastrointestinal stromal tumor (GIST).
PackAge:
ProductionCapacity:|Metric Ton|Day
Storage:
Transportation:

Superiority:

This product is a derivative of phenylpyrimidine, a new tyrosine kinase inhibitor.

It is used for the treatment of chronic myelocytic leukemia (CML) in various stages. It is also used to treat CD117 positive gastrointestinal stromal tumor (GIST).

Details:

This product is a derivative of phenylpyrimidine, a new tyrosine kinase inhibitor.

It is used for the treatment of chronic myelocytic leukemia (CML) in various stages. It is also used to treat CD117 positive gastrointestinal stromal tumor (GIST).

View All